Author:
Zhou Nina,Bilimoria Sara,Lio Peter A.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Advanced and Specialized Nursing
Reference38 articles.
1. Dupilumab side effect in a patient with atopic dermatitis: A case report study;Biologics: Targets & Therapy,2019
2. The oral Janus kinase/spleen tyrosine kinase inhibitor ASN002 demonstrates efficacy and improves associated systemic inflammation in patients with moderate-to-severe atopic dermatitis: Results from a randomized double-blind placebo-controlled study;The British Journal of Dermatology,2019
3. Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): A 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial;Lancet (London, England),2017
4. Expert perspectives on management of moderate-to-severe atopic dermatitis: A multidisciplinary consensus addressing current and emerging therapies;The Journal of Allergy and Clinical Immunology. In Practice,2017
5. Atopic dermatitis: Immune deviation, barrier dysfunction, IgE autoreactivity and new therapies;Allergology International,2017
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献